These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8172599

  • 21. The influence of the cysteine protease inhibitor L-trans-epoxysuccinyl-leucyl amido(4-guanidio)butane (E64) on photobiological effects of tetra(4-sulfonatophenyl)porphine.
    Berg K, Moan J.
    Cancer Lett; 1995 Jan 27; 88(2):227-36. PubMed ID: 7874697
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Specificity of cathepsin B to fluorescent substrates containing benzyl side-chain-substituted amino acids at P1 subsite.
    Del Nery E, Alves LC, Melo RL, Cesari MH, Juliano L, Juliano MA.
    J Protein Chem; 2000 Jan 27; 19(1):33-8. PubMed ID: 10882170
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Inhibition of papain with 2-benzyl-3,4-epoxybutanoic acid esters. Mechanistic and stereochemical probe for cysteine protease catalysis.
    Kim DH, Jin Y, Ryu CH.
    Bioorg Med Chem; 1997 Nov 27; 5(11):2103-8. PubMed ID: 9416427
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of interleukin 1-stimulated cartilage proteoglycan degradation by a lipophilic inactivator of cysteine endopeptidases.
    Buttle DJ, Saklatvala J, Tamai M, Barrett AJ.
    Biochem J; 1992 Jan 01; 281 ( Pt 1)(Pt 1):175-7. PubMed ID: 1731753
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors.
    Turk D, Podobnik M, Popovic T, Katunuma N, Bode W, Huber R, Turk V.
    Biochemistry; 1995 Apr 11; 34(14):4791-7. PubMed ID: 7718586
    [Abstract] [Full Text] [Related]

  • 30. E-64c-hydrazide: a lead structure for the development of irreversible cathepsin C inhibitors.
    Radzey H, Rethmeier M, Klimpel D, Grundhuber M, Sommerhoff CP, Schaschke N.
    ChemMedChem; 2013 Aug 11; 8(8):1314-21. PubMed ID: 23780739
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The cysteine proteinase inhibitor, E-64, reduces proteinuria in an experimental model of glomerulonephritis.
    Baricos WH, O'Connor SE, Cortez SL, Wu LT, Shah SV.
    Biochem Biophys Res Commun; 1988 Sep 30; 155(3):1318-23. PubMed ID: 3178811
    [Abstract] [Full Text] [Related]

  • 33. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors.
    Turk B, Turk V, Turk D.
    Biol Chem; 1997 Sep 30; 378(3-4):141-50. PubMed ID: 9165064
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of the selective and non-selective cysteine protease inhibitors on the intracellular processing of interleukin 6 by HEPG2 cells.
    Peppard JV, Knap AK.
    In Vitro Cell Dev Biol Anim; 1999 Sep 30; 35(8):459-64. PubMed ID: 10501085
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.